Evidence map›Paper›PMID 42230991›Full record

ArticleNature biotechnology2026

Programmable, multiplexed and orthogonal gene control in bacteria with attenuated Cas13d systems.

Shengkun Tong, Yuxi Qin, Yaqian Sun, Yaojie Gao, Muyi Song, Tao Fang, Yaojun Tong

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shengkun TongState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Yuxi QinState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Yaqian SunState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Yaojie GaoState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Muyi SongState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Tao FangState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Yaojun TongState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. yaojun.tong@sjtu.edu.cn.ORCID http://orcid.org/0000-0003-4042-2462

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2021YFA0909500Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2025YFE0198900National Natural Science Foundation of China (National Science Foundation of China) 32170080National Natural Science Foundation of China (National Science Foundation of China) 32370026National Natural Science Foundation of China (National Science Foundation of China) 32500035Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 24HC2810200Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) 25XF3200100
6 · The paper itself

Abstract

Cas13-based RNA effectors may enable dynamic, multiplexed and reversible gene regulation in bacteria. Yet, their widespread adoption is hindered by inherent cytotoxicity and collateral cleavage. Here we present a rational protein engineering strategy to generate attenuated Cas13d variants with tunable RNase activity through targeted truncation of flexible regions. This permits effective transcript knockdown while greatly reducing toxicity as reflected by a 2.2-fold higher growth optical density. By introducing proximal mismatches at the 5' end of CRISPR RNA spacers, our system allows functional switching between translation inhibition, polycistronic mRNA degradation and IF3-fusion-based translation-level CRISPR activation. We demonstrate programmable, orthogonal and multiplexed regulation of individual genes within polycistronic mRNAs and synthetic circuits. Application to lycopene biosynthesis optimization shows robust pathway rewiring and improved yields alongside fine-tuned modulation of essential and competing pathways in Escherichia coli. Our work provides a versatile RNA-regulatory toolkit for next-generation microbial synthetic biology and RNA-based biotechnology.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.